BioVie Inc.
BIVI
$0.8408
$0.04766.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.11M | -4.15M | -4.94M | -8.07M | -8.40M |
| Total Depreciation and Amortization | 57.30K | 57.30K | 57.30K | 57.30K | 57.30K |
| Total Amortization of Deferred Charges | 2.40K | 9.50K | 16.50K | 23.60K | 30.70K |
| Total Other Non-Cash Items | 701.00K | 576.80K | 1.71M | 1.20M | 306.80K |
| Change in Net Operating Assets | -2.23M | -71.10K | -851.00K | 934.70K | 2.10M |
| Cash from Operations | -8.58M | -3.58M | -4.01M | -5.85M | -5.91M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.35M | -2.50M | -2.50M | -2.50M | -2.50M |
| Issuance of Common Stock | 16.32M | 2.26M | 0.00 | 18.48M | 7.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.97M | -240.90K | -2.50M | 15.98M | 4.92M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.38M | -3.82M | -6.51M | 10.12M | -988.00K |